Skip to main content
  • Home
  • About Us
  • Advisory Board
  • Advertise
  • Editorial Submissions
  • Contact Us
  • Subscribe to Newsletter

  • Follow me on Twitter
  • Friend me on Facebook
  • Connect with me on LinkedIn
  • Subscribe to me on YouTube
  • Subscribe to my RSS Feed

Menu

Skip to content
  • MedTech Economics
  • Policy
  • Manufacturing Execution
  • Product Design & Development
  • Quality & Compliance
  • Digital Health
  • Resource Library
  • Events & Webinars


Justice scale, healthcare, cost
April 6, 2021
Justice scale, healthcare, cost

Data-Document Continuum: Why Life Sciences Transformation Depends on Companies Overcoming Information Silos

By MedTech Intelligence Staff

Companies within the life sciences industry should rethink how they manage their data and documents.

Continue reading →

Shawn LaRocco, ServiceMax
March 31, 2021
Shawn LaRocco, ServiceMax
Soapbox

Crucial Metrics for Medical Device Manufacturers: Cost-to-Serve (Part 2)

By Shawn LaRocco

Understanding the cost to service by product and by subcomponent will help you identify which service events are the most impactful to the bottom-line financials of the business.

Continue reading →

Erik Vanderlip, M.D., ZoomCare
March 26, 2021
Erik Vanderlip, M.D., ZoomCare
MEDdesign

COVID-19 Pushes Technology to Facilitate Hybrid Patient Care

By Erik Vanderlip, M.D.

Increased access to care is a vital part of the vision to innovate the delivery of healthcare.

Continue reading →

Boston Scientific
March 23, 2021
Boston Scientific

Boston Scientific Settles Surgical Mesh Claims for Nearly $189 Million

By MedTech Intelligence Staff

The company was accused of hiding serious health risks related to implantation of its transvaginal surgical mesh products.

Continue reading →

Tanya Kumari, Classic Informatics
March 22, 2021
Tanya Kumari, Classic Informatics
Soapbox

Digital Health Trends In 2021

By Tanya Kumari

Data, IoT, artificial intelligence, predictive analytics, virtual and augmented reality, and many other technologies will fuel the healthcare system.

Continue reading →

Ivana Schnur, Sensely
March 17, 2021
Ivana Schnur, Sensely
MEDdesign

Are We Finally Ready for Virtual Reality Medical Treatments?

By Ivana Schnur, M.D.

The normalization of digital healthcare will go a long way toward driving uptake of new technologies.

Continue reading →

Shawn LaRocco, ServiceMax
March 16, 2021
Shawn LaRocco, ServiceMax
Soapbox

Crucial Metrics for Medical Device Manufacturers: Contract Profitability (Part 1)

By Shawn LaRocco

Contract profitability requires real-time visibility into assets so manufacturers can make decisions proactively rather than reactively and maintain customer excellence.

Continue reading →

Louis Lehot, L2Counsel
March 11, 2021
Louis Lehot, L2Counsel
Soapbox

Five Market, Investment, and M&A Trends in MedTech Meet Five Legal and Policy Issues

By Louis Lehot

Medtech businesses show tremendous potential for profitability and growth, triggering a sparked interest in investment.

Continue reading →

Coronavirus
March 5, 2021
Coronavirus

First At-Home, Molecular OTC Diagnostic Test for COVID-19 Wins FDA Authorization

By MedTech Intelligence Staff

The test generates results within 20 minutes and can be used by adults and children over the age of two years old.

Continue reading →

Donna Morrow, Noteworth
March 3, 2021
Donna Morrow, Noteworth
Soapbox

Virtual Optimism: Keep Remote Patient Monitoring and Telemedicine in Your Post-Pandemic Care Delivery Mix

By Donna Morrow

As restrictions lift and in-person visits become viable again, the use of virtual care technology — particularly telemedicine and remote patient monitoring (RPM)—is here to stay.

Continue reading →

Post navigation

  • Previous
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 98
  • Next

Upcoming Events & Webinars

No posts found.



On Demand Events & Webinars

No posts found.






Columns

August 10, 2026

What 524B and QMSR Change About Medical Device Risk

By Kaleb Averell
Balancing Cyber Risk

What 524B and QMSR actually require, in plain terms, including the post-market obligation that does not end at clearance? How both map to four kinds of exposure: cybersecurity, product liability, recall, and management liability. Where device makers are commonly unprepared against the new baseline, including the gap between cyber risk and product liability for software and devices.

August 10, 2026

Why Few MedTech Sales Teams Are Using AI Where It Matters Most

By Lee Smith

A MedTech survey revealed that most sales teams are not using AI for strategic purposes, such as identifying opportunities, prioritizing accounts, or research. Instead, AI is mostly deployed to complete administrative tasks, such as drafting emails and summarizing meetings. Why is more needed?

June 22, 2026

CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences

By MedTech Intelligence Staff

CMS’s proposed expansion of Medicare TAVR coverage to include select asymptomatic severe aortic stenosis patients and reduce access barriers for symptomatic patients could significantly increase TAVR adoption, creating a growth opportunity for Edwards Lifesciences through expanded eligibility, higher procedure volumes, and continued leadership in structural heart care.

June 8, 2026

Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals

By MedTech Intelligence Staff
Medtronic Logo

Medtronic announced several regulatory milestones for its Hugo robotic-assisted surgery platform, including FDA submissions for general and gynecologic surgery indications and the LigaSure™ RAS instrument, alongside FDA clearance for its ProGrip™ Advanced hernia mesh. The developments expand the company's robotic surgery portfolio and support its growth strategy in minimally invasive surgical care.

June 8, 2026

Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses

By MedTech Intelligence Staff
Medtronic Logo

Medtronic reported robust fiscal 2026 results, fueled by strong growth in cardiovascular, medical surgical, and diabetes technologies, while advancing key product launches, regulatory milestones, and strategic acquisitions.

June 8, 2026

Boston Scientific Plans Indiana Distribution Center, 300 New Jobs

Boston Scientific

Boston Scientific will invest $138 million to build a 500,000-square-foot global medical device distribution facility in Plainfield, Indiana, creating up to 300 high-wage jobs and expanding the state's growing life sciences sector.

May 20, 2026

Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity

By Peter Justen

MTI Viewpoints Insights shared by industry relative to healthcare and the advancement of medical technology. Peter Justen is Founder and CEO of AmeriTrust Solutions. He works at the intersection of technology, data, and human-centered design to improve access to government...

May 20, 2026

The failure of the ‘usual suspects’ approach to life science recruitment

By Ivor Campbell

How has AI impacted the way in which companies recruit for senior specialists, particularly in highly niche roles in MedTech, biotech and pharmaceutical development? Finding the right people for these roles has never been harder.

TOPICS

  • Digital Health
  • MedTech Economics
  • Manufacturing Execution
  • Product Design & Development
  • Quality/Regulatory

Upcoming Events & Webinars

No posts found.

Contact Us

  • Advertising Opportunities
  • Editorial Submissions
  • General Inquiries
  • Privacy Policy
  • Cookie Policy
  • Sign Up for Newsletters

Innovative Publishing Company, Inc.

  • FoodSafetyTech
  • Food Safety Consortium Conference & Expo
  • MedTech Intelligence
  • Cannabis Industry Journal

© Copyright 2015 - 2026 Innovative Publishing Co., Inc., All Rights Reserved

Other Innovative Publishing Co., Inc. Sites: Food Safety Tech  |  Cannabis Industry Journal

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

MedTech Intelligence
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

We use tracking pixels that set your arrival time at our website, this is used as part of our anti-spam and security measures. Disabling this tracking pixel would disable some of our security measures, and is therefore considered necessary for the safe operation of the website. This tracking pixel is cleared from your system when you delete files in your history.

We also use cookies to store your preferences regarding the setting of 3rd Party Cookies.

Cookie Policy

A browser cookie is a small piece of data that is stored on your device to help websites and mobile apps remember things about you. Other technologies, including Web storage and identifiers associated with your device, may be used for similar purposes. In this policy, we say “cookies” to discuss all of these technologies.

Our Privacy Policy explains how we collect and use information from and about you when you use This website and certain other Innovative Publishing Co LLC services. This policy explains more about how we use cookies and your related choices.

How We Use Cookies

Data generated from cookies and other behavioral tracking technology is not made available to any outside parties, and is only used in the aggregate to make editorial decisions for the websites. Most browsers are initially set up to accept cookies, but you can reset your browser to refuse all cookies or to indicate when a cookie is being sent by visiting this Cookies Policy page. If your cookies are disabled in the browser, neither the tracking cookie nor the preference cookie is set, and you are in effect opted-out.

In other cases, our advertisers request to use third-party tracking to verify our ad delivery, or to remarket their products and/or services to you on other websites. You may opt-out of these tracking pixels by adjusting the Do Not Track settings in your browser, or by visiting the Network Advertising Initiative Opt Out page.

You have control over whether, how, and when cookies and other tracking technologies are installed on your devices. Although each browser is different, most browsers enable their users to access and edit their cookie preferences in their browser settings. The rejection or disabling of some cookies may impact certain features of the site or to cause some of the website’s services not to function properly.

Individuals may opt-out of 3rd Party Cookies used on IPC websites by adjusting your cookie preferences through this Cookie Preferences tool, or by setting web browser settings to refuse cookies and similar tracking mechanisms. Please note that web browsers operate using different identifiers. As such, you must adjust your settings in each web browser and for each computer or device on which you would like to opt-out on. Further, if you simply delete your cookies, you will need to remove cookies from your device after every visit to the websites. You may download a browser plugin that will help you maintain your opt-out choices by visiting www.aboutads.info/pmc. You may block cookies entirely by disabling cookie use in your browser or by setting your browser to ask for your permission before setting a cookie. Blocking cookies entirely may cause some websites to work incorrectly or less effectively.

The use of online tracking mechanisms by third parties is subject to those third parties’ own privacy policies, and not this Policy. If you prefer to prevent third parties from setting and accessing cookies on your computer, you may set your browser to block all cookies. Additionally, you may remove yourself from the targeted advertising of companies within the Network Advertising Initiative by opting out here, or of companies participating in the Digital Advertising Alliance program by opting out here.